← back to search

Matthew Perez

University of South Florida · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Melanoma and MAPK Pathways, and Cancer Immunotherapy and Biomarkers.
h-index
20
citations
1,132
works
89
NIH funding
primary concept
email

Recent publications

The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
Annals of Oncology 2024cited by 35position: middledoi
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
Journal for ImmunoTherapy of Cancer 2022cited by 15position: middledoi
Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)
Cancer 2021cited by 61position: middledoi
Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
Annals of Surgical Oncology 2020cited by 44position: middledoi
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Journal of the American College of Surgeons 2020cited by 23position: middledoi
Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience
Journal of the American College of Surgeons 2019cited by 96position: middledoi
Observational Study of Talimogene Laherparepvec use for Melanoma in Clinical Practice in the United States (COSMUS-1)
Melanoma Management 2019cited by 30position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jonathan S. Zager · University of Alabama at Birmingham3 papers (2019–2020)Keith A. Delman · Emory University2 papers (2019–2020)Michael Lowe · Adelphi Group (United Kingdom)2 papers (2019–2020)Evan Wuthrick · The Ohio State University1 papers (2020–2020)Bradley R. Corr · University of Colorado System1 papers (2024–2024)Vanda Salutari · Woman's Hospital1 papers (2024–2024)Elisabeth Diver · AbbVie (United States)1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Leon Raskin · Amgen (United States)1 papers (2019–2019)Stefanie J Soelling · Brigham and Women's Hospital1 papers (2020–2020)Vernon K. Sondak · Advanced Dermatology1 papers (2020–2020)Raphael J. Louie · Dartmouth College1 papers (2019–2019)Angeles Alvarez Secord · Duke University1 papers (2024–2024)Attiya Harit · University of South Florida1 papers (2020–2020)Robert M. Conry · University of Alabama at Birmingham1 papers (2019–2019)Clara R. Farley · Emory Healthcare1 papers (2020–2020)Isabelle Ray‐Coquard · Université Claude Bernard Lyon 11 papers (2024–2024)Sharyn N. Lewin · Columbia University1 papers (2024–2024) · 1 papers (2024–2024)